Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 12, 2014, Pages

  Leyden, Jan E ^a   Moss, Alan C ^b   Macmathuna, Padraic ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; ANTIPARKINSON AGENT;

BALLOON DILATATION; CLINICAL EFFECTIVENESS; DRUG EFFICACY; ENDOSCOPIC PNEUMATIC DILATION; ENDOSCOPIC THERAPY; ESOPHAGUS ACHALASIA; ESOPHAGUS MANOMETRY; ESOPHAGUS PERFORATION; EVIDENCE BASED MEDICINE; HUMAN; LOWER ESOPHAGUS SPHINCTER PRESSURE; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; REMISSION; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; CATHETERIZATION; DILATATION; ESOPHAGEAL ACHALASIA; META ANALYSIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); TIME;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; CATHETERIZATION; DILATATION; ESOPHAGEAL ACHALASIA; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; TIME FACTORS;

EID: 84925226113     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005046.pub3     Document Type: Review

References (38)

1. Annese V, Basciani M, Perri F, Lombardi G, Frusciante V, Simone P, et al. Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology 1996;111(6):1418-24. [MEDLINE: 310]
2. Bansal R, Nostrant TT, Scheiman JM, Koshy S, Barnett JL, Elta GH, et al. Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia. Journal of Clinical Gastroenterology 2003;36(3):209-14. [MEDLINE: 311]
3. Ghoshal UC, Chaudhuri S, Pal BB, Dhar K, Ray G, Banerjee PK. Randomized controlled trial of intrasphincteric botulinum toxin A injection versus balloon dilatation in treatment of achalasia cardia. Diseases of the Esophagus 2001;14(3-4):227-31. [MEDLINE: 2]
4. Mikaeli J, Fazel A, Montazeri G, Yaghoobi M, Malekzadeh R. Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Alimentary Pharmacology and Therapeutics 2001;15(9):1389-96. [MEDLINE: 312]
5. Muehldorfer SM, Schneider TH, Hochberger J, Martus P, Hahn EG, Ell C. Esophageal achalasia: intrasphincteric injection of botulinum toxin A versus balloon dilation. Endoscopy 1999;31(7):517-21. [MEDLINE: 313]
6. Vaezi MF, Richter JE, Wilcox CM, Schroeder PL, Birgisson S, Slaughter RL, et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut 1999;44(2):231-9. [MEDLINE: 5]
7. Zhu Q, Liu J, Yang C. Clinical study on combined therapy of botulinum toxin injection and small balloon dilation in patients with esophageal achalasia. Digestive Surgery 2009;26:493-8.
8. Allescher HD, Storr M, Seige M, Gonzales-Donoso R, Ott R, Born P, et al. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-up. Endoscopy 2001;33(12):1007-17. [MEDLINE: 1]
9. Bansal R, Koshy S, Scheiman JM, Barnett JL, Nostrant TT. Interim analysis of a randomized trial of Witzel pneumatic dilation vs intrasphincteric injection of botulinum toxin (Botox) for achalasia. Gastroenterology 1996;110(4):A56. [MEDLINE: 279]
10. des Varannes SB, Lemiere S, Guillemot JF, Ducrotte P, Zerbib F, Rolachon A, et al. Botulinum toxin versus pneumatic dilatation in achalasia: Results of a multicentre controlled trial. Gastroenterology 1999;116(4):G0557. [MEDLINE: 191]
11. Gaudric M, Guimbaud R, Chaussade S, Palazzo L, Quartier G, Samama J, et al. Pneumatic dilatation (PD) versus intrasphincteric botulinum toxin (BT) in the treatment of achalasia: Preliminary results of a controlled study. Gastroenterology 1996;110(4):A667. [MEDLINE: 284]
12. Jung HE, Lee JS, Kim JO, Hong SJ, Lee TH, Kim HG, et al. The long-term outcome in patients with primary achalasia according to the balloon dilatation or intrasphincteric botulinum toxin injection. Neurogastroenterology and Motility 2012;24 Suppl 2:97.
13. Linghu E, Li H. Randomized study comparing peroral endoscopic myotomy, botulinum toxin injection and balloon dilation for achalasia: one-year follow-up. Program and abstracts of the American College of Gastroenterology 2013 Annual Scientific Meeting; October 11-16, 2013; San Diego, California. American Journal of Gastroenterology 2013;108:Abstract 28.
14. Malekzadeh R, Milkaeli J, Fazel A, Montazeri G, Yaghoobi M, Khatibian M, et al. A randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for treatment of achalasia. Gastrointestinal Endoscopy 2000;51(4):4468. [MEDLINE: 149]
15. Muehldorfer SM, Schneider T, Hochberger J, Hahn EG, Ell C. Intrasphincteric injection of botulinum toxin A versus balloon dilation in patients with achalasia. A randomized prospective comparative trial. Gastrointestinal Endoscopy 1998;47(4):199. [MEDLINE: 225]
16. Nebendahl JC, Brand B, von Schrenck T, Matsui U, Thonke F, Bohnacker S, et al. Prospective randomised comparison of dilation (high compliance balloon) vs. botulinum toxin injection (BTX) in esophageal achalasia. Gastroenterology 1998;114(4):G0985. [MEDLINE: 218]
17. Zhou H, Dai Y, Lu L, Luo S, Qian Y, Wan X. Endoscopic water-filled balloon dilatation and botulinum toxin injection for treatment of achalasia: A comparison of clinical effectiveness. Academic Journal of Second Military Medical University 2012;33(9):1000-6.
18. Annese V, Basciani M, Borrelli O, Leandro G, Simone P, Andriulli A. Intrasphincteric injection of botulinum toxin is effective in long-term treatment of esophageal achalasia. Muscle & Nerve 1998;21:1540-2.
19. Bassotti G, Annese V. Pharmacological options in achalasia. Alimentary Pharmacology & Therapeutics 1999;13:1391-6.
20. Cuilliere C, Ducrotte P, Zerbib F, et al. Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 1997;41:87-92.
21. Eckardt VF, Kohne U, Junginger T, Westermeier T. Risk factors for diagnostic delay in achalasia. Digestive Diseases and Sciences 1997;42(3):580-5.
22. Frantzides CT, Moore RE, Carlson MA, et al. Minimally invasive surgery for achalasia: a 10-year experience. Journal of Gastrointestinal Surgery 2004;8(1):18-23.
23. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration 2008. Available from www.cochrane-handbook.org.
24. Howard PJ. Maher L, Pryde A, et al. Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edingburgh. Gut 1992;33:1011-5.
25. Imperiale TF, O'Connor JB, Vaezi MF, Richter JE. A cost-minimization analysis of alternative treatment strategies for achalasia. The American Journal of Gastroenterology 2000;95(10):2737-45.
26. Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 2010;42:265-71.
27. Kadakia SC, Wong RK. Pneumatic balloon dilation for esophageal achalasia. Gastrointestinal Endoscopy Clinics of North America 2001;11(2):325-46.
28. Katz PO, Gilbert J, Costell D. Pneumatic dilation is effective long-term treatment for achalasia. Digestive Diseases and Sciences 1998;43:1973-7.
29. Kolbasnik J, Waterfall WE, Fachnie B, Chen Y, Tougas G. Long-term efficacy of Botulinum toxin in classical achalasia: a prospective study. The American Journal of Gastroenterology 1999;94(12):3434-9.
30. Mayberry JF, Atkinson M. Variations in the prevalence of achalasia in Great Britain and Ireland: an epidemiological study based on hospital admissions. The Quarterly Journal of Medicine 1987;62:67-74.
31. Pasricha PJ, Ravich WJ, Hendric TR, Kalloo AN. Treatment of achalasia with intrasphincteric injection of botulinum toxin: a pilot trial. Annals of Internal Medicine 1994;121:590-1.
32. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Botulinum toxin for the treatment of achalasia. The New England Journal of Medicine 1995;322:774-8.
33. Pasricha PJ, Hawari R, Ahmed I, Chen J, Cotton PB, Hawes RH, et al. Submucosal endoscopic esophageal myotomy: a novel experimental approach for the treatment of achalasia. Endoscopy 2007;39:761-4.
34. Reynolds, JC, Parkman, HP. Achalasia. Gastroenterology Clinics of North America 1989;18:223.
35. Urbach DR, Hansen PD, Khajanchee YS, Swanstrom LL. A decision analysis of the optimal initial approach to achalasia: laparoscopic Heller myotomy with partial fundoplication, thoracoscopic Heller myotomy, pneumatic dilatation, or botulinum toxin injection. Journal of Gastrointestinal Surgery 2001;5(2):192-205.
36. Vela MF, Richter JE, Wachsberger D, Connor J, Rice TW. Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilatation, Heller myotomy, and botulinum toxin injection. The American Journal of Gastroenterology 2004;99(6):1029-36.
37. Von Renteln D, Fuchs KH, Fockens P, Bauerfeind P, Vassiliou MC, Werner YB, et al. Peroral endoscopic myotomy for the treatment of achalasia: an international prospective multicenter study. Gastroenterology 2013;145(2):309-11.
38. Wen ZH, Gardener E, Wang YP. Nitrates for achalasia. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD002299.pub2]